Australie - anglais - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - methenamine hippurate, quantity: 1000 mg - tablet, uncoated - excipient ingredients: magnesium stearate; povidone; colloidal anhydrous silica - prophylaxis or suppression of bacteriuria associated with chronic or recurrent infection of the urinary tract.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - methenamine hippurate, quantity: 1000 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; povidone; magnesium stearate - prophylaxis or suppression of bacteriuria associated with chronic or recurrent infection of the urinary tract.

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - methenamine hippurate 1 g (1.005g hexamine hippurate with aerosil);  ;  ;  ;   - tablet - 1 g - active: methenamine hippurate 1 g (1.005g hexamine hippurate with aerosil)         excipient: magnesium stearate povidone - label claim: prophylaxis or supression of urinary tract bacteria

États-Unis - anglais - NLM (National Library of Medicine)

clarion brands, llc - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), sodium salicylate (unii: wiq1h85syp) (salicylic acid - unii:o414pz4lpz) - methenamine............antibacterial sodium salicylate.....analgesic (pain reliever) use temporarily relieves - pain & burning - frequency and urgency of urination - if you are allergic to salicylates (including aspirin) - frequent, burning urination for the first time - the stomach bleeding warning applying to you - history of stomach problems, such as heartburn - high blood pressure - heart disease - liver cirrhosis - bleeding problems - diuretic use - ulcers - kidney disease - a sodium restricted diet - reach age 60 or older - taking any other drug containing an nsaid (prescription or non-prescription) - taking a blood thinning (anticoagulant), steroid, diabetes, gout or arthritis drug - product has been used for 3 days - ringing in the ears - you experience any of the following signs of stomach bleeding: feel faint vomit blood have bloody or black stools have stomach pain or upset that gets worse or lasts - feel faint - vomit blood - have bloody or black stools - have stomach pain or upset that gets worse or lasts

États-Unis - anglais - NLM (National Library of Medicine)

drug ocean llc - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), sodium salicylate (unii: wiq1h85syp) (salicylic acid - unii:o414pz4lpz) - purpose antibacterial analgesic (pain reliever) uses temporarily relieves: - pain & burning - frequency and urgency of urination

Canada - anglais - Health Canada

searchlight pharma inc - methenamine mandelate - tablet - 500mg - methenamine mandelate 500mg - urinary anti-infectives

États-Unis - anglais - NLM (National Library of Medicine)

method pharmaceuticals - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), methylene blue anhydrous (unii: 8nap7826ub) (methylene blue cation - unii:zmz79891zh), hyoscyamine sulfate anhydrous (unii: ob570z127k) (hyoscyamine - unii:px44xo846x) - methenamine 81.6 mg - there have been no studies to establish the safety of prolonged use in humans. no known long-term animal studies have been performed to evaluate carcinogenic potential. a dependence on the use of me/naphos/mb/hyo 1 tablets has not been reported and due to the nature of its ingredients, abuse of me/naphos/mb/hyo 1 tablets is not expected.

États-Unis - anglais - NLM (National Library of Medicine)

method pharmaceuticals, llc - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), sodium phosphate, monobasic, anhydrous (unii: kh7i04hpuu) (sodium cation - unii:lyr4m0nh37), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - methenamine 81 mg - uro-458 tablets is indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. uro-458 tablets is contraindicated in patients with a hypersensitivity to any of the ingredients. risk-benefit should be considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis; acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy).

Australie - anglais - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - methenamine hippurate, quantity: 1 g - tablet, uncoated - excipient ingredients: povidone; magnesium stearate; colloidal anhydrous silica - suppression of bacteriuria associated with chronic or recurrent infection of the urinary tract. may be used for short or long term therapy, as necessary.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - methenamine hippurate, quantity: 1000 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; povidone; magnesium stearate - prophylaxis or suppression of bacteriuria associated with chronic or recurrent infection of the urinary tract.